Hosted on MSN

Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), formed from the 2020 merger of Mylan ...
Drug Store News

Viatris receives FDA nod for generic Venofer injection

The Food and Drug Administration has given Viatris permission for iron sucrose injection, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients ...
Monthly Prescribing Reference

FDA Approves First Generic Version of Venofer Injection

All 3 strengths of iron sucrose injection are expected to be available “imminently”. The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection ...
Nasdaq

Viatris: FDA Approves First Generic Iron Sucrose Injection

(RTTNews) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients with ...
Hosted on MSN

Viatris wins FDA nod for generic iron sucrose injection targeting Daiichi’s Venofer

Viatris (NASDAQ:VTRS) announced on Monday that the U.S. FDA has approved its Iron Sucrose Injection, USP, as a generic product targeting Venofer marketed by Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) ...
Mena FN

Iron Sucrose Injection Market Bargains New Insights Post Covid Impact Analysis | AMAG, American Regent, Daiichi Sankyo, International Brands

Latest released the research study on Global Iron Sucrose Injection Market , offers a detailed overview of the factors influencing the global business scope. Iron Sucrose Injection Market research ...